H.R.1392 - To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.111th Congress (2009-2010)
Summary: H.R.1392 — 111th Congress (2009-2010)
Introduced in House (03/09/2009)
Amends title XVIII (Medicare) of the Social Security Act with respect to the use of average sales price methodology for calculating payments for drugs and biologicals under Medicare part B (Supplementary Medical Insurance).
Excludes from the manufacturer's average sales price when calculating such payments any customary prompt pay discounts extended to wholesalers.